메뉴 건너뛰기




Volumn 148, Issue 15, 2004, Pages 730-735

Extent and quality of anti-coagulation treatment with coumarin derivatives by the Dutch Thrombosis Services;Omvang en kwaliteit van de antistollingsbehandeling met cumarinederivaten door de Nederlandse Trombosediensten

Author keywords

[No Author keywords available]

Indexed keywords

ACENOCOUMAROL; ANTICOAGULANT AGENT; COUMARIN DERIVATIVE; PHENPROCOUMON;

EID: 1842763799     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (28)

References (22)
  • 1
    • 0037813859 scopus 로고    scopus 로고
    • Rochester: Mayo Foundation for Medical Education and Research
    • Owen CA. A history of blood coagulation. Rochester: Mayo Foundation for Medical Education and Research; 2001. P. 264-7.
    • (2001) A History of Blood Coagulation , pp. 264-267
    • Owen, C.A.1
  • 5
    • 0027948583 scopus 로고
    • Oral anticoagulation in the prevention of one-year vein graft occlusion after aortocoronary bypass surgery: Optimal therapeutic range and practical limitations
    • CABADAS Research Group of the Interuniversity Cardiology Institute of the Netherlands
    • Meer J van der, Hillege HL, Dunselman PH, Mulder BJ, Michels HR, Buser PT, et al. Oral anticoagulation in the prevention of one-year vein graft occlusion after aortocoronary bypass surgery: optimal therapeutic range and practical limitations. CABADAS Research Group of the Interuniversity Cardiology Institute of the Netherlands. Thromb Haemost 1994;72:676-81.
    • (1994) Thromb Haemost , vol.72 , pp. 676-681
    • Van Der Meer, J.1    Hillege, H.L.2    Dunselman, P.H.3    Mulder, B.J.4    Michels, H.R.5    Buser, P.T.6
  • 7
    • 0031455701 scopus 로고    scopus 로고
    • A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin
    • The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. Ann Neurol 1997; 42:857-65.
    • (1997) Ann Neurol , vol.42 , pp. 857-865
  • 8
    • 0035099824 scopus 로고    scopus 로고
    • Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery
    • Dutch BOA Study Group
    • Tangelder MJD, Algra A, Lawson JA, Hennekes S, Eikelboom BC. Optimal oral anticoagulant intensity to prevent secondary ischemic and hemorrhagic events in patients after infrainguinal bypass graft surgery. Dutch BOA Study Group. J Vasc Surg 2001;33:522-7.
    • (2001) J Vasc Surg , vol.33 , pp. 522-527
    • Tangelder, M.J.D.1    Algra, A.2    Lawson, J.A.3    Hennekes, S.4    Eikelboom, B.C.5
  • 10
    • 0042387879 scopus 로고    scopus 로고
    • Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation
    • Hylek EM, Go AS, Chang Y, Jensvold NG, Henault LE, Selby NV, et al. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation. N Engl J Med 2003;349:1019-26.
    • (2003) N Engl J Med , vol.349 , pp. 1019-1026
    • Hylek, E.M.1    Go, A.S.2    Chang, Y.3    Jensvold, N.G.4    Henault, L.E.5    Selby, N.V.6
  • 11
    • 0037202697 scopus 로고    scopus 로고
    • Antistollingsbehandeling bij patiënten met boezemfibrilleren: Afhankelijk van leeftijd en andere risicofactoren voor trombo-embolie
    • Vink R, Brink RBA van den, Levi M. Antistollingsbehandeling bij patiënten met boezemfibrilleren: afhankelijk van leeftijd en andere risicofactoren voor trombo-embolie. Ned Tijdschr Geneeskd 2003; 146:2285-9.
    • (2003) Ned Tijdschr Geneeskd , vol.146 , pp. 2285-2289
    • Vink, R.1    Van Den Brink, R.B.A.2    Levi, M.3
  • 12
    • 0034460484 scopus 로고    scopus 로고
    • Effects of warfarin, aspirin and the two combined, on mortality and thromboembolic morbidity after myocardial infarction. The WARIS-II (Warfarin-Aspirin Reinfarction Study) design
    • Hurlen M, Smith P, Arnesen H. Effects of warfarin, aspirin and the two combined, on mortality and thromboembolic morbidity after myocardial infarction. The WARIS-II (Warfarin-Aspirin Reinfarction Study) design. Scand Cardiovasc J 2000;34:168-71.
    • (2000) Scand Cardiovasc J , vol.34 , pp. 168-171
    • Hurlen, M.1    Smith, P.2    Arnesen, H.3
  • 13
    • 0037072090 scopus 로고    scopus 로고
    • Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): A randomised controlled trial
    • Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis-2 (ASPECT-2) Research Group
    • Es RF van, Jonker JJ, Verheugt FW, Deckers JW, Grobbee DE. Antithrombotics in the Secondary Prevention of Events in Coronary Thrombosis-2 (ASPECT-2) Research Group. Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial. Lancet 2002;360:109-13.
    • (2002) Lancet , vol.360 , pp. 109-113
    • Van Es, R.F.1    Jonker, J.J.2    Verheugt, F.W.3    Deckers, J.W.4    Grobbee, D.E.5
  • 14
    • 0031001452 scopus 로고    scopus 로고
    • Efficacy and safety of lower molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery; a meta-analysis of randomised clinical trials
    • Palmer AJ, Koppenhagen K, Kirchhof B, Weber U, Bergemann R. Efficacy and safety of lower molecular weight heparin, unfractionated heparin and warfarin for thrombo-embolism prophylaxis in orthopaedic surgery; a meta-analysis of randomised clinical trials. Haemostasis 1997;27:75-84.
    • (1997) Haemostasis , vol.27 , pp. 75-84
    • Palmer, A.J.1    Koppenhagen, K.2    Kirchhof, B.3    Weber, U.4    Bergemann, R.5
  • 16
    • 0037068999 scopus 로고    scopus 로고
    • Bleeding risks of anti-thrombotic therapy
    • Fitzmaurice DA, Blann AD, Lip GYH. Bleeding risks of anti-thrombotic therapy. BMJ 2002;325:828-31.
    • (2002) BMJ , vol.325 , pp. 828-831
    • Fitzmaurice, D.A.1    Blann, A.D.2    Lip, G.Y.H.3
  • 18
    • 15844427401 scopus 로고    scopus 로고
    • Bleeding complications of oral anticoagulant treatment: An inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy
    • Palareti G, Leali N, Coccheri S, Poggi M, Manotti C, D'Angelo A, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy. Lancet 1996; 348:423-8.
    • (1996) Lancet , vol.348 , pp. 423-428
    • Palareti, G.1    Leali, N.2    Coccheri, S.3    Poggi, M.4    Manotti, C.5    D'Angelo, A.6
  • 19
    • 0036283541 scopus 로고    scopus 로고
    • Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon
    • Gadisseur APA, Meer FJM van der, Adriaansen HJ, Fihn SD, Rosendaal FR. Therapeutic quality control of oral anticoagulant therapy comparing the short-acting acenocoumarol and the long-acting phenprocoumon. Br J Haematol 2002;117:940-6.
    • (2002) Br J Haematol , vol.117 , pp. 940-946
    • Gadisseur, A.P.A.1    Van Der Meer, F.J.M.2    Adriaansen, H.J.3    Fihn, S.D.4    Rosendaal, F.R.5
  • 20
    • 0034603468 scopus 로고    scopus 로고
    • Postoperatieve wondinfecties: Een bruikbare indicator voor de kwaliteit van zorg?
    • Casparie AF. Postoperatieve wondinfecties: een bruikbare indicator voor de kwaliteit van zorg? Ned Tijdschr Geneeskd 2000;144:460-2.
    • (2000) Ned Tijdschr Geneeskd , vol.144 , pp. 460-462
    • Casparie, A.F.1
  • 21
    • 0011705769 scopus 로고    scopus 로고
    • Paradigma's van kwaliteit
    • Berg M, Schellekens W. Paradigma's van kwaliteit. Med Contact 2002;57:1203-6.
    • (2002) Med Contact , vol.57 , pp. 1203-1206
    • Berg, M.1    Schellekens, W.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.